Close Menu

NEW YORK – Biotia, a startup providing DNA sequencing-based microbial surveillance services and infectious disease diagnostic tests for hospitals, said Tuesday that it has closed a $2.4 million seed financing round.

Falcon III Ventures, a Boston-based biotech fund, led the round, with participation from other venture capital firms and angel investors, according to Biotia. 

The company also added Barry Zeman, Don Goldmann, and Steven Salzberg to its scientific and clinical advisory board. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.